🇺🇸 FDA
Patent

US 10961301

Cell-penetrating anti-DNA antibodies and uses thereof inhibit DNA repair

granted A61KA61K2039/505A61K31/337

Quick answer

US patent 10961301 (Cell-penetrating anti-DNA antibodies and uses thereof inhibit DNA repair) held by The United States Government represented by the Department of Veterans Affairs expires Mon Mar 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States Government represented by the Department of Veterans Affairs
Grant date
Tue Mar 30 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K2039/505, A61K31/337, A61K31/475, A61K31/513